Gh Research Plc (GHRS)

Jan 10, 2025, 7:00 AM EST - 8 days ago

GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents

Nov 14, 2024, 7:00 AM EST - 2 months ago

GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates

Sep 3, 2024, 7:05 AM EDT - 4 months ago

GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates

Sep 3, 2024, 7:00 AM EDT - 4 months ago

GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer

May 3, 2024, 7:00 AM EDT - 9 months ago

GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates

Feb 29, 2024, 7:00 AM EST - 11 months ago

GH Research Reports Full Year 2023 Financial Results and Provides Business Updates

Jan 18, 2024, 4:30 PM EST - 1 year ago

GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression

Nov 9, 2023, 4:45 PM EST - 1 year ago

GH Research Reports Third Quarter Financial Results and Provides Business Updates

Sep 29, 2023, 4:45 PM EDT - 1 year ago

GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression

Aug 23, 2023, 7:00 AM EDT - 1 year ago

GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates

Jun 16, 2023, 11:06 AM EDT - 1 year ago

GH Research: But Toad Venom Is A Controlled Substance

May 11, 2023, 7:30 AM EDT - 1 year ago

GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights

Mar 2, 2023, 7:00 AM EST - 2 years ago

GH Research Reports Full Year 2022 Financial Results and Provides Business Updates

Jan 15, 2023, 11:45 AM EST - 2 years ago

Psychedelic Sunday: Competitive Strategies

ATAI CMPS CYBN MNMD

Jan 9, 2023, 7:30 AM EST - 2 years ago

GH Research Provides Business Updates and Highlights Key Upcoming Milestones

Nov 10, 2022, 7:05 AM EST - 2 years ago

GH Research Reports Third Quarter 2022 Financial Results and Provides Business Updates

Aug 23, 2022, 7:00 AM EDT - 2 years ago

GH Research Reports Second Quarter 2022 Financial Results and Provides Business Updates

May 18, 2022, 7:00 AM EDT - 2 years ago

GH Research Reports First Quarter 2022 Financial Results and Provides Business Updates

Mar 28, 2022, 7:04 AM EDT - 3 years ago

GH Research Reports Full Year 2021 Financial Results and Provides Business Updates

Jan 19, 2022, 4:31 PM EST - 3 years ago

Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today

Dec 6, 2021, 2:16 PM EST - 3 years ago

GH Research Announces Positive Trial Results For Treatment-Resistant Depression

Dec 6, 2021, 10:15 AM EST - 3 years ago

GH Research Posts Data From Treatment-Resistant Depression Trial

Dec 6, 2021, 7:10 AM EST - 3 years ago

GH Research Reports Third Quarter 2021 Financial Results and Provides Business Updates

Sep 23, 2021, 5:25 PM EDT - 3 years ago

GH Research PLC Provides Business Updates and Reports Second Quarter 2021 Financial Results

Aug 15, 2021, 3:55 AM EDT - 3 years ago

GH Research: A Recent IPO Stock That Could Possibly Be A Trailblazer In A Hot Industry

Jun 25, 2021, 1:23 PM EDT - 3 years ago

7 Companies Go Public Today. What Investors Need to Know.

ELEV MCW TKNO ACXP

Jun 22, 2021, 8:25 PM EDT - 3 years ago

GH Research Seeks $125 Million IPO